PCM
Perkins Capital Management Portfolio holdings
AUM
$99.5M
This Quarter Return
-1.51%
1 Year Return
+49.19%
3 Year Return
+174.89%
5 Year Return
+322.89%
10 Year Return
–
AUM
$106M
AUM Growth
+$106M
(-11%)
Cap. Flow
-$4.74M
Cap. Flow
% of AUM
-4.47%
Top 10 Holdings %
Top 10 Hldgs %
44.3%
Holding
92
New
2
Increased
11
Reduced
51
Closed
4
Top Buys
| 1 |
Biodesix
BDSX
|
$635K |
| 2 |
Moderna
MRNA
|
$437K |
| 3 |
Personalis
PSNL
|
$301K |
| 4 |
Magnite
MGNI
|
$276K |
| 5 |
AtriCure
ATRC
|
$59.2K |
Top Sells
| 1 |
FlexShopper
FPAY
|
$613K |
| 2 |
Veracyte
VCYT
|
$372K |
| 3 |
Rekor Systems
REKR
|
$344K |
| 4 |
Medtronic
MDT
|
$294K |
| 5 |
Natera
NTRA
|
$279K |
Sector Composition
| 1 | Healthcare | 58.06% |
| 2 | Technology | 26.21% |
| 3 | Communication Services | 5.31% |
| 4 | Consumer Staples | 4.28% |
| 5 | Industrials | 3.18% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
26
Pfizer
PFE
$141B
| $1.28M | 1.2% |
45,675
-66
| -0.1% | -$1.85K |
|
|
AUGX
27
DELISTED
Augmedix, Inc. Common Stock
AUGX
| $1.25M | 1.18% |
1,417,068
-41,200
| -3% | -$36.3K |
|
28
Village Farms International
VFF
$291M
| $1.11M | 1.04% |
1,083,500
-29,500
| -3% | -$30.1K |
|
29
Target
TGT
$42B
| $1.08M | 1.01% |
7,275
-200
| -3% | -$29.6K |
|
30
MDxHealth
MDXH
$178M
| $1.05M | 0.99% |
437,875
+22,650
| +5% | +$54.2K |
|
31
OptimizeRx
OPRX
$326M
| $1.02M | 0.96% |
102,363
-3,100
| -3% | -$31K |
|
32
Apple
AAPL
$3.54T
| $979K | 0.92% |
4,650
| – | – |
|
33
TELA Bio
TELA
$65.4M
| $960K | 0.9% |
204,350
-5,650
| -3% | -$26.5K |
|
34
Tactile Systems Technology
TCMD
$295M
| $925K | 0.87% |
77,500
-2,400
| -3% | -$28.6K |
|
35
ConocoPhillips
COP
$118B
| $915K | 0.86% |
8,000
| – | – |
|
|
STRM
36
DELISTED
Streamline Health Solutions
STRM
| $906K | 0.85% |
1,965,405
-31,500
| -2% | -$14.5K |
|
37
Exagen
XGN
$213M
| $898K | 0.85% |
493,321
-250
| -0.1% | -$455 |
|
|
38
Moderna
MRNA
$9.36B
| $876K | 0.83% |
7,375
+3,675
| +99% | +$437K |
|
39
SkyWater Technology
SKYT
$514M
| $855K | 0.81% |
111,750
-6,000
| -5% | -$45.9K |
|
40
Gilead Sciences
GILD
$140B
| $853K | 0.8% |
12,433
-500
| -4% | -$34.3K |
|
41
Ciena
CIEN
$13.4B
| $807K | 0.76% |
16,750
| – | – |
|
|
42
FlexShopper
FPAY
$17.9M
| $797K | 0.75% |
622,750
-479,193
| -43% | -$613K |
|
43
AT&T
T
$208B
| $743K | 0.7% |
38,876
-166
| -0.4% | -$3.17K |
|
44
Bristol-Myers Squibb
BMY
$96.7B
| $706K | 0.67% |
16,991
+350
| +2% | +$14.5K |
|
|
45
AtriCure
ATRC
$1.73B
| $693K | 0.65% |
30,450
+2,600
| +9% | +$59.2K |
|
46
Baxter International
BAX
$12.1B
| $686K | 0.65% |
20,509
| – | – |
|
47
Castle Biosciences
CSTL
$673M
| $677K | 0.64% |
31,090
-1,050
| -3% | -$22.9K |
|
48
Verizon
VZ
$184B
| $673K | 0.63% |
16,308
-309
| -2% | -$12.8K |
|
49
NXP Semiconductors
NXPI
$57.5B
| $659K | 0.62% |
2,450
| – | – |
|
50
Backblaze
BLZE
$474M
| $658K | 0.62% |
106,835
| – | – |
|